Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Salivary Gland Neoplasms 1Osteosarcoma 1Gastrointestinal Stromal Tumors 1Gastric Adenocarcinoma 1Esophageal Squamous Cell Carcinoma 1Cholangiocarcinoma 1Breast Neoplasms 1Biliary Tract Neoplasms 1Advanced Gastric Cancer 1Adebrelimab 1

Interventions

apatinib 1SHR-1701 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Gastric Cancer × apatinib × 90 days × Clear all
NCT07294664 2026-04-16

PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer

The First Affiliated Hospital of Zhengzhou University

Phase 2 Recruiting
78 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡